Comparison between Avience Biomedicals IPO and Medistep Healthcare IPO.
Avience Biomedicals IPO is a SME Fixed Price IPO proposed to list at NSE SME while Medistep Healthcare IPO is a SME Fixed Price proposed to list at NSE SME.
| Avience Biomedicals IPO | Medistep Healthcare IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Fixed Price |
| Listing At | NSE SME | NSE SME |
| Lead Managers | Fintellectual Corporate Advisors Pvt.Ltd. | Novus Capital Advisors Private Limited |
| Registrar | Skyline Financial Services Pvt.Ltd. | Cameo Corporate Services Ltd. |
| Market Maker | Asnani Stock Broker Pvt.Ltd. | Nirman Share Brokers Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | ||
| Final Prospectus | Final Prospectus | |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL |
The total issue size of Avience Biomedicals IPO is up to ₹0.00 Cr whereas the issue size of the Medistep Healthcare IPO is up to ₹15.29 Cr. The final issue price of Avience Biomedicals IPO is and of Medistep Healthcare IPO is ₹43.00 per share.
| Avience Biomedicals IPO | Medistep Healthcare IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ₹43.00 per share | |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 3000 shares | |
| Fresh Issue Size | 15,27,600 shares | 35,55,000 shares |
| Fresh Issue Size (Amount) | up to ₹0.00 Cr | up to ₹15.29 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 15,27,600 shares | 35,55,000 shares |
| Issue Size Total (Amount) | up to ₹0.00 Cr | up to ₹15.29 Cr |
Avience Biomedicals IPO opens on , while Medistep Healthcare IPO opens on Aug 08, 2025. The closing date of Avience Biomedicals IPO and Medistep Healthcare IPO is , and Aug 12, 2025, respectively.
| Avience Biomedicals IPO | Medistep Healthcare IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Aug 08, 2025 | |
| Issue Close | Aug 12, 2025 | |
| Basis Of Allotment (Tentative) | Aug 13, 2025 | |
| Initiation of Refunds (Tentative) | Aug 14, 2025 | |
| Credit of Share (Tentative) | Aug 14, 2025 | |
| Listing date (Tentative) | Aug 18, 2025 | |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Avience Biomedicals IPO P/E ratio is , as compared to Medistep Healthcare IPO P/E ratio of 10.86.
| Avience Biomedicals IPO | Medistep Healthcare IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)Avience Biomedicals Ltd.'s revenue increased by 89% and profit after tax (PAT) rose by 239% between the financial year ending with March 31, 2025 and March 31, 2024.
| Company Financials (Restated Standalone)Medistep Healthcare Ltd.'s revenue increased by 27% and profit after tax (PAT) rose by 25% between the financial year ending with March 31, 2025 and March 31, 2024.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 92.85 | 93.62 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 66.37 | 68.96 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 10.86 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹61.10 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 50.14 | 29.06 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 24.84 | 38.91 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.97 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹3.96 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 50.14 | 29.06 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Avience Biomedicals IPO Retail Individual Investors (RII) are offered 0 shares while in Medistep Healthcare IPO retail investors are offered 0 shares. Qualified Institutional Buyers (QIB) are offered 0 shares in Avience Biomedicals IPO and 0 shares in Medistep Healthcare IPO.
| Avience Biomedicals IPO | Medistep Healthcare IPO | |
|---|---|---|
| Anchor Investor Reservation | ||
| Market Maker Reservation | 80,400 shares | 1,89,000 shares |
| QIB | 0 shares | 0 shares |
| NII | 0 shares | 17,76,000 shares |
| RII | 0 shares | 17,79,000 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 0 shares | 35,55,000 shares |
Avience Biomedicals IPO subscribed in total, whereas Medistep Healthcare IPO subscribed 382.14x.
| Avience Biomedicals IPO | Medistep Healthcare IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | 289.15x | |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 461.11x | |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 382.14x |
